Sanofi

Pursue Progress. Discover Extraordinary.

Science has been our calling from the beginning. Sanofi’s heritage of turning the impossible into the possible stretches back to the 19th century — a rich history of healthcare innovation built by diverse companies united by one shared purpose. More than 150 years later, that spirit lives in everything we do and every person we serve — from the patients who take our medicines, to the healthcare professionals who trust us, to the 83,000+ employees and communities around the world who make it all possible. And today, we’re writing the next chapter of that legacy.

We are an R&D-driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth.

Better is out there. Better medications, better outcomes, better science. And it all starts with people like you — from different backgrounds, in different locations, doing different roles — united by a single mission: we chase the miracles of science to improve people’s lives.

Take the most important step in your career and help us change the lives of patients, families, and communities for the better.

Explore Open Roles →

  • Featured Employer
What could we achieve together? Sign up today and discover our latest opportunities as soon as they’re available.
Reinvention is in our DNA. It’s what drove our evolution from a small French enterprise to one of the world’s leading biopharma companies — present in 70+ countries and growing. Whether it’s harnessing AI to shorten drug-discovery timelines, pioneering transformative treatments, or building trust in healthcare systems worldwide, you could be helping our teams make life better for patients, partners, and communities.

This is where you grow your career. We open the door for you to explore new roles, take on stretch assignments, and connect with people driven by a shared purpose. Our culture of high performance and belonging is grounded in four core values:: Aim Higher, Act for Patients, Be Bold, and Lead Together.

At Sanofi, we believe every person can lead from where they are. You’ll learn to grow your skills and evolve as a leader through our Leadership Frame. Connect with mentors via our Career Hub, and explore new possibilities through “gigs”, where you’ll work on short-term projects to try something new on another team. You’ll do it all with our full support, increasing your exposure to business leaders, and expanding your network across the industry.
All Well, together. We support healthy bodies, healthy minds, healthy financials, and a healthy working culture for all Sanofians. Our dedication to improving people’s lives starts at home, with the health and wellbeing of our employees and their families.
We want you to share your voice and challenge us, even when it might feel uncomfortable. We’ll help turn your ideas into action, based on tangible measures. Because it’s action, not intent, that makes change sustainable and gives us our Diversity Edge.

We’re the first in pharma to have a Diversity, Equity and Inclusion (DE&I) Board with external members. And every member of our Executive Committee is represented either on the DE&I board or as a sponsor of a global Employee Resource Group (ERG). Diversity is our strength. Boldly, proudly and unapologetically. We’re All In on DE&I. Come and be part of it.
What is the Sanofi Feeling?

You are unique. How you feel on any given day is unique. Who you are with, and the environment you’re in, has the power to shape and enhance how you feel. At Sanofi, it’s not just about the chair you sit in. We’ve blended art with science and looked at every detail to match your uniqueness.

We’re transforming healthcare and improving lives through our work, our people, and our stories. You’ll get a glimpse of what life here is like, you’ll hear inspiring stories and you’ll dive into the projects that reveal the miracles of science. Let’s live extraordinarily.
AWARDS
  • Sanofi Human Rights Campaign award.png
  • Sanofi award_usa-2.png
  • Sanofi award_usa-3.png
  • 2023 Best Places to Work
  • 2022 Best Places to Work
NEWS
The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, bringing in almost $700 million in the third quarter. Leerink Partners analyst David Risinger in a Friday note to investors said Sanofi expects Q4 Beyfortus sales similar to Q3.
Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French government taking a stake as well to ensure the business remains in the county.
Thursday’s agreement with Orano Med is the second in as many months. Sanofi in September made its first foray into the radioligand space with a $110 million licensing deal with Orano Med and Texas biotech RadioMedix.
Artificial intelligence won’t replace people in biopharma, but it is infiltrating every step of drug development, including in some ways that aren’t so obvious.
Sanofi looks to follow a deep history of Big Pharma offloading their consumer healthcare businesses.
Analysts expect the partners’ first-mover advantage, clinical data and existing presence in lung disease to translate into significant sales, with GlobalData predicting Dupixent’s COPD revenues will top $6.5 billion within 10 years.
Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic lateral sclerosis, forcing the company to discontinue its development a few months later.
Big Pharma can’t seem to get enough radiopharmaceutical biotechs. With Lilly, Sanofi and BMS chasing Novartis into the complex space, all eyes are on these specialty biotechs.
Under the deal announced Friday, the Italian pharma will make an upfront payment of $825 million to Sanofi for global rights to a biologic for the treatment of cold agglutinin disease, with milestone payments of up to $250 million.
JOBS
IN THE PRESS